126 related articles for article (PubMed ID: 36854058)
1. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts.
Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
[TBL] [Abstract][Full Text] [Related]
2. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
Risch HA; Yu H; Lu L; Kidd MS
J Natl Cancer Inst; 2010 Apr; 102(7):502-5. PubMed ID: 20181960
[TBL] [Abstract][Full Text] [Related]
3. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis.
Schulte A; Pandeya N; Fawcett J; Fritschi L; Risch HA; Webb PM; Whiteman DC; Neale RE
Cancer Causes Control; 2015 Jul; 26(7):1027-35. PubMed ID: 25951801
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.
Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W
Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer: A Meta-Analysis Based on Nested Case-Control Studies.
Chen XZ; Wang R; Chen HN; Hu JK
Pancreas; 2015 Nov; 44(8):1340-4. PubMed ID: 26390415
[TBL] [Abstract][Full Text] [Related]
6. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori seropositivities and risk of pancreatic carcinoma.
Risch HA; Lu L; Kidd MS; Wang J; Zhang W; Ni Q; Gao YT; Yu H
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):172-8. PubMed ID: 24234587
[TBL] [Abstract][Full Text] [Related]
9. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
10. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of
Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
[TBL] [Abstract][Full Text] [Related]
12. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects.
Simán JH; Engstrand L; Berglund G; Florén CH; Forsgren A
Clin Diagn Lab Immunol; 2005 Feb; 12(2):304-9. PubMed ID: 15699426
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.
Stolzenberg-Solomon RZ; Blaser MJ; Limburg PJ; Perez-Perez G; Taylor PR; Virtamo J; Albanes D;
J Natl Cancer Inst; 2001 Jun; 93(12):937-41. PubMed ID: 11416115
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori seropositivity and risk of lung cancer.
Koshiol J; Flores R; Lam TK; Taylor PR; Weinstein SJ; Virtamo J; Albanes D; Perez-Perez G; Caporaso NE; Blaser MJ
PLoS One; 2012; 7(2):e32106. PubMed ID: 22384154
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
20. Associations between seroprevalence of
Khosravi AD; Sirous M; Saki M; Seyed-Mohammadi S; Modares Mousavi SR; Veisi H; Abbasinezhad Poor A
J Int Med Res; 2021 Dec; 49(12):3000605211058870. PubMed ID: 34875914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
